Active — Not RecruitingNot Applicable

An Evaluation of Concordance of Smartwatch ECG and One Clinical ECG and Comparison of The Two ECGS in Terms of Predictive Risks

United States1,303 participantsStarted 2022-12-13

Plain-language summary

The participant is being asked to take part in this trial, because the participant is a survivor of childhood cancer. Primary Objective To evaluate remote cardiomyopathy prediction via smartwatch and one clinical ECG and assess the concordance of the two ECGs in terms of predicted risk. Secondary Objective To build a novel predictive model solely on smartwatch ECG to predict risk for cardiomyopathy.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * SJLIFE participant and 22 years of age or older at time of enrollment * Participant or legal guardian is able and willing to give informed consent * At least 5 years after childhood cancer diagnosis Exclusion Criteria: * Been diagnosed with cardiomyopathy on previous SJLIFE ECG * Currently on heart medication

What they're measuring

Standard 12-lead ECG

Timeframe: Baseline

Apple Smartwatch ECG 30-second recording

Timeframe: Baseline

Trial details

NCT IDNCT05617391

SponsorSt. Jude Children's Research Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-17

View on ClinicalTrials.gov More Childhood Cancer trials